DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+40.96%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$3.13B
AUM Growth
+$3.13B
(+28%)
Cap. Flow
+$61.4M
Cap. Flow
% of AUM
1.96%
Top 10 Holdings %
Top 10 Hldgs %
43.58%
Holding
109
New
14
Increased
23
Reduced
25
Closed
30
Top Buys
| 1 |
AdaptHealth
AHCO
|
$189M |
| 2 |
Tandem Diabetes Care
TNDM
|
$54.1M |
| 3 |
Rhythm Pharmaceuticals
RYTM
|
$39M |
| 4 |
Ardelyx
ARDX
|
$27M |
| 5 |
Korro Bio
KRRO
|
$24.9M |
Top Sells
Sector Composition
| 1 | Healthcare | 77.68% |
| 2 | Financials | 0.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AdaptHealth
AHCO
$1.28B
| $189M | 6.03% | +17,199,888 | New | +$189M |
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $172M | 5.48% | 4,742,311 -1,720,323 | -27% | -$62.3M |
|
3
Viatris
VTRS
$12.3B
| $164M | 5.23% | 8,151,754 +497,689 | +7% | +$10M |
|
|
ORTX
4
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $122M | 3.89% | 8,862,247 -61,353 | -0.7% | -$844K |
|
5
Q32 Bio
QTTB
$20.9M
| $109M | 3.46% | 5,245,638 -514,730 | -9% | -$10.7M |
|
|
6
Rhythm Pharmaceuticals
RYTM
$6.85B
| $98.5M | 3.14% | 4,289,291 +1,700,000 | +66% | +$39M |
|
7
Mirum Pharmaceuticals
MIRM
$3.71B
| $84.6M | 2.7% | 3,448,912 | – | – |
|
|
8
Tandem Diabetes Care
TNDM
$845M
| $81.2M | 2.59% | 1,361,345 +907,011 | +200% | +$54.1M |
|
|
XLRN
9
DELISTED
Acceleron Pharma Inc.
XLRN
| $72.6M | 2.32% | 1,369,625 +64,451 | +5% | +$3.42M |
|
|
RARX
10
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $71.3M | 2.28% | 1,519,718 -208,301 | -12% | -$9.78M |
|
11
Centene
CNC
$14.3B
| $69.7M | 2.22% | 1,108,400 +388,000 | +54% | +$24.4M |
|
|
XENT
12
DELISTED
Intersect ENT, Inc
XENT
| $69.6M | 2.22% | 2,797,033 -311,971 | -10% | -$7.77M |
|
|
MYOK
13
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $57.5M | 1.83% | 789,000 -192,430 | -20% | -$14M |
|
|
14
Ardelyx
ARDX
$1.53B
| $52.6M | 1.68% | 7,004,253 +3,603,843 | +106% | +$27M |
|
15
Brookdale Senior Living
BKD
$1.83B
| $52.5M | 1.68% | 7,223,419 +16,180 | +0.2% | +$118K |
|
|
SILK
16
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $51.7M | 1.65% | 1,279,480 +300,000 | +31% | +$12.1M |
|
|
DBVT
17
DBV Technologies
DBVT
$264M
| $50.9M | 1.62% | 4,756,000 +1,554,778 | +49% | +$16.6M |
|
18
Rocket Pharmaceuticals
RCKT
$354M
| $49.3M | 1.57% | 2,164,471 +390,533 | +22% | +$8.89M |
|
19
Vericel Corp
VCEL
$1.83B
| $47.8M | 1.53% | 2,747,563 +666,563 | +32% | +$11.6M |
|
|
BPMC
20
DELISTED
Blueprint Medicines
BPMC
| $45.3M | 1.44% | 564,914 +187,714 | +50% | +$15M |
|
21
Arvinas
ARVN
$568M
| $44.7M | 1.43% | 1,088,234 +167,000 | +18% | +$6.86M |
|
|
AERI
22
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $42.8M | 1.37% | 1,772,255 -2,796,569 | -61% | -$67.6M |
|
23
Fate Therapeutics
FATE
$120M
| $39.2M | 1.25% | 2,002,605 +49,708 | +3% | +$973K |
|
|
SIEN
24
DELISTED
Sientra, Inc.
SIEN
| $37.8M | 1.21% | 4,227,680 +90,210 | +2% | +$806K |
|
|
IMMU
25
DELISTED
Immunomedics Inc
IMMU
| $36.5M | 1.16% | 1,722,618 -1,491,382 | -46% | -$31.6M |
|